🇺🇸
United States · US · US:47426-503_ab2a0921-41d7-4b3b-ace9-6adccb12c5e9
ZYNRELEF
Orange BookUNIISPLATC N01BB
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerHeron Therapeutics, Inc.
CountryUS (United States)
ATC codeN01BB
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1147426503011 CARTON in 1 KIT (47426-503-01) / 1 VIAL, SINGLE-DOSE in 1 CARTON (47426-503-03) / 2.3 mL in 1 VIAL, SINGLE-DOSE
Annotations
UNII (FDA Substance ID)
Y8335394RO
BUPIVACAINE
RxCUI 1815
Orange Book
N211988
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "Y8335394RO",
"rxcui": "1815",
"inchikey": "LEBVLXFERQHONN-UHFFFAOYSA-N",
"display_name": "BUPIVACAINE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INFILTRATION",
"spl_meta": {
"dab484a7-9353-43ba-9e74-7fab910c712b": {
"match": "brand_token",
"title": "ZYNRELEF (BUPIVACAINE AND MELOXICAM) SOLUTION [HERON THERAPEUTICS, INC.]",
"spl_version": "16",
"published_date": "2026-04-30"
}
},
"productid": "47426-503_ab2a0921-41d7-4b3b-ace9-6adccb12c5e9",
"productndc": "47426-503",
"dosage_form": "SOLUTION",
"orange_book": {
"appl_no": "211988",
"products": [
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "60MG/2.3ML (29.25MG/ML);1.8MG/2.3ML (0.88MG/ML)",
"product_no": "001",
"approval_date": "May 12, 2021"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "200MG/7ML (29.25MG/ML);6MG/7ML (0.88MG/ML)",
"product_no": "002",
"approval_date": "May 12, 2021"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "300MG/10.5ML (29.25MG/ML);9MG/10.5ML (0.88MG/ML)",
"product_no": "003",
"approval_date": "May 12, 2021"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "400MG/14ML (29.25MG/ML);12MG/14ML (0.88MG/ML)",
"product_no": "004",
"approval_date": "May 12, 2021"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "BUPIVACAINE; MELOXICAM",
"proprietary_name": "ZYNRELEF",
"active_ingred_unit": "mg/7mL; mg/7mL",
"application_number": "NDA211988",
"marketing_category": "NDA",
"nonproprietary_name": "BUPIVACAINE and MELOXICAM",
"start_marketing_date": "20241201",
"active_numerator_strength": "200; 6"
}Related drugs
Other records sharing ATC code N01BB.
- GBAnestadent 4% and 1:100,000 solution for injection 2.2ml cartridgesDentsply Ltd
- 🇺🇸ArticadentDentsply Pharmaceutical
- 🇺🇸ArticadentDentsply Pharmaceutical
- 🇺🇸ARTICAINENDC, Inc.
- 🇺🇸ARTICAINENovocol Pharmaceutical of Canada, Inc.
- 🇺🇸ARTICAINEBenco Dental
- 🇺🇸ARTICAINEBenco Dental
- 🇺🇸ARTICAINENovocol Pharmaceutical of Canada, Inc.
Access this data programmatically
Query ZYNRELEF and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.